These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

630 related articles for article (PubMed ID: 34496197)

  • 1. On Preliminary Findings of mRNA Covid-19 Vaccine Safety in Pregnant Persons.
    Sun H
    N Engl J Med; 2021 Oct; 385(16):1535-1536. PubMed ID: 34496197
    [No Abstract]   [Full Text] [Related]  

  • 2. On Preliminary Findings of mRNA Covid-19 Vaccine Safety in Pregnant Persons. Reply.
    Meaney-Delman DM; Ellington SR; Shimabukuro TT
    N Engl J Med; 2021 Oct; 385(16):1536. PubMed ID: 34496198
    [No Abstract]   [Full Text] [Related]  

  • 3. Re: Short-term outcome of pregnant women vaccinated with BNT162b2 mRNA COVID-19 vaccine.
    Mungmunpuntipantip R; Wiwanitkit V
    Ultrasound Obstet Gynecol; 2021 Dec; 58(6):958. PubMed ID: 34855292
    [No Abstract]   [Full Text] [Related]  

  • 4. mRNA Covid-19 Vaccines in Pregnant Women.
    Riley LE
    N Engl J Med; 2021 Jun; 384(24):2342-2343. PubMed ID: 34133864
    [No Abstract]   [Full Text] [Related]  

  • 5. Effectiveness of Messenger RNA Coronavirus Disease 2019 (COVID-19) Vaccines Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection in a Cohort of Healthcare Personnel.
    Swift MD; Breeher LE; Tande AJ; Tommaso CP; Hainy CM; Chu H; Murad MH; Berbari EF; Virk A
    Clin Infect Dis; 2021 Sep; 73(6):e1376-e1379. PubMed ID: 33900384
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Positive aspects of the mRNA platform for SARS-CoV-2 vaccines.
    Hajissa K; Mussa A
    Hum Vaccin Immunother; 2021 Aug; 17(8):2445-2447. PubMed ID: 33830862
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coronavirus Disease 2019 (COVID-19) Vaccines and Pregnancy: What Obstetricians Need to Know.
    Rasmussen SA; Kelley CF; Horton JP; Jamieson DJ
    Obstet Gynecol; 2021 Mar; 137(3):408-414. PubMed ID: 33370015
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current Data on COVID-19 mRNA-Vaccine Safety during Pregnancy Might Be Subject to Selection Bias. Reply to Stroobandt, S.; Stroobandt, R. Data of the COVID-19 mRNA-Vaccine V-Safe Surveillance System and Pregnancy Registry Reveals Poor Embryonic and Second Trimester Fetal Survival Rate. Comment on "Stuckelberger et al. SARS-CoV-2 Vaccine Willingness among Pregnant and Breastfeeding Women during the First Pandemic Wave: A Cross-Sectional Study in Switzerland.
    Stuckelberger S; Favre G; Ceulemans M; Gerbier E; Lambelet V; Stojanov M; Winterfeld U; Baud D; Panchaud A; Pomar L
    Viruses; 2021 Aug; 13(8):. PubMed ID: 34452411
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine.
    Skowronski DM; De Serres G
    N Engl J Med; 2021 Apr; 384(16):1576-1577. PubMed ID: 33596348
    [No Abstract]   [Full Text] [Related]  

  • 10. Safety Surveillance of COVID-19 mRNA Vaccines Through the Vaccine Safety Datalink.
    Blumenthal KG; Phadke NA; Bates DW
    JAMA; 2021 Oct; 326(14):1375-1377. PubMed ID: 34477809
    [No Abstract]   [Full Text] [Related]  

  • 11. Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine. Reply.
    Absalon J; Koury K; Gruber WC
    N Engl J Med; 2021 Apr; 384(16):1578. PubMed ID: 33596351
    [No Abstract]   [Full Text] [Related]  

  • 12. Data of the COVID-19 mRNA-Vaccine V-Safe Surveillance System and Pregnancy Registry Reveals Poor Embryonic and Second Trimester Fetal Survival Rate. Comment on Stuckelberger et al. SARS-CoV-2 Vaccine Willingness among Pregnant and Breastfeeding Women during the First Pandemic Wave: A Cross-Sectional Study in Switzerland.
    Stroobandt S; Stroobandt R
    Viruses; 2021 Aug; 13(8):. PubMed ID: 34452410
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety of BNT162b2 mRNA COVID-19 vaccine in patients with mast cell disorders.
    Rosman Y; Lavi N; Meir-Shafrir K; Lachover-Roth I; Cohen-Engler A; Mekori YA; Confino-Cohen R
    J Allergy Clin Immunol Pract; 2021 Sep; 9(9):3487-3489. PubMed ID: 34224924
    [No Abstract]   [Full Text] [Related]  

  • 14. [Single dose of SARS-CoV-2 mRNA vaccine in post-COVID-19 elderly people].
    Nieto Colino S; Cid Abasolo FJ; Martínez Hernández J
    Rev Esp Geriatr Gerontol; 2021; 56(5):312-313. PubMed ID: 34172313
    [No Abstract]   [Full Text] [Related]  

  • 15. Temporal Associations Between Immunization With the COVID-19 mRNA Vaccines and Myocarditis: The Vaccine Safety Surveillance System Is Working.
    Navar AM; McNally E; Yancy CW; O'Gara PT; Bonow RO
    JAMA Cardiol; 2021 Oct; 6(10):1117-1118. PubMed ID: 34185044
    [No Abstract]   [Full Text] [Related]  

  • 16. Counseling in maternal-fetal medicine: SARS-CoV-2 infection in pregnancy.
    Di Mascio D; Buca D; Berghella V; Khalil A; Rizzo G; Odibo A; Saccone G; Galindo A; Liberati M; D'Antonio F
    Ultrasound Obstet Gynecol; 2021 May; 57(5):687-697. PubMed ID: 33724545
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Experience with SARS-CoV-2 BNT162b2 mRNA vaccine in dialysis patients.
    Yanay NB; Freiman S; Shapira M; Wishahi S; Hamze M; Elhaj M; Zaher M; Armaly Z
    Kidney Int; 2021 Jun; 99(6):1496-1498. PubMed ID: 33887318
    [No Abstract]   [Full Text] [Related]  

  • 18. How important is the second dose of the COVID-19 mRNA vaccine?
    Liu AY
    J Allergy Clin Immunol Pract; 2021 Jun; 9(6):2537. PubMed ID: 34112480
    [No Abstract]   [Full Text] [Related]  

  • 19. Localized cutaneous reaction to an mRNA COVID-19 vaccine.
    Edriss M; Farshchian M; Daveluy S
    J Cosmet Dermatol; 2021 Aug; 20(8):2380-2381. PubMed ID: 34129749
    [No Abstract]   [Full Text] [Related]  

  • 20. In high-risk adults, the Moderna vaccine had 94% efficacy against COVID-19 ≥14 d after the 2nd dose.
    Chagla Z
    Ann Intern Med; 2021 Mar; 174(3):JC28. PubMed ID: 33646836
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.